NCT00336466View on ClinicalTrials.gov

The Erythropoietin NeuroProtective Effect: Assessment in CABG Surgery (TENPEAKS)

PHASE2CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

May 31, 2005

Conditions

Cardiac SurgeryBrain Injury

Interventions

DRUG

Human recombinant erythropoietin

Trial Locations (1)

T2N 2T9

Foothills Hospital, Calgary

Sponsors

Collaborators (1)

Ortho Biotech, Inc.

All Listed Sponsors

collaborator

Calgary Health Region

OTHER

collaborator

Ortho Biotech, Inc.

INDUSTRY

lead

University of Calgary

OTHER